|

APG-2449 Clinical Trials

2 actively recruiting trials

Also known as: APG-2449 Capsule

Pipeline

Phase 1: 2

Top Sponsors

  • Ascentage Pharma Group Inc.2

Indications

  • Cancer2
  • Platinum-resistant Recurrent Ovarian Cancer1
  • Malignant Pleural Mesothelioma1
  • Advanced Solid Cancer1
  • Advanced Solid Tumor1

Other2 trials

APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST
Phase 1
APG-2449 in Patients With Advanced Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.